「ph」の検索結果
582件：361～365件目を表示
もしかして
-
General Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr....
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Cong...
https://www.senju.co.jp/english/rd/society/ -
Business Activities | About Senju | SENJU Pharmaceutical
d a development policy that puts top priority on safety, we have always taken a pioneering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future,...
https://www.senju.co.jp/english/about/business/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Cong...
http://www.senju.co.jp/english/rd/society/